CBR1 and chronic obstructive pulmonary disease: In this context, we hypothesize that PRDX1 and CBR1, as typical oxidation–reduction-related enzymes, might participate in regulating cellular oxidative stress, sensing, or influencing lactate-related signaling pathways, thereby contributing to the chronic inflammation and immune microenvironment regulation in COPD.